May 27 (Reuters) - SENSORION SA ALSEN.PA :
* SENSORION ANNOUNCES THE SIGNATURE OF A PARTNERSHIP
FRAMEWORK
AGREEMENT WITH INSTITUT PASTEUR ON GENE THERAPY PROGRAMS
TARGETING HEARING LOSS
* AGREEMENT DEFINES AN EXCLUSIVE OPTION TO OBTAIN LICENCES
FOR
JOINT PROGRAMS INCLUDING OTOFERLIN & USHER TYPE 1
* AGREEMENT DEFINES PREFERENCE RIGHTS ON RESEARCH PIPELINE
IN
FIELD OF GENETIC DISORDERS OF INNER EAR IN ORDER TO SET UP
FUTURE COLLABORATIONS
Source text for Eikon: ID:nBw6Z3fD0a
Further company coverage: ALSEN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))